{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:48:56Z","timestamp":1761130136658},"reference-count":57,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,31]]},"DOI":"10.7759\/cureus.53336","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:49:05Z","timestamp":1706748545000},"source":"Crossref","is-referenced-by-count":1,"title":["Role of Surgical and Medical Management of Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Alexandra V","family":"Crowley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Banfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhea","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasavi R","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2021000282","article-title":"Chronic thromboembolic pulmonary hypertension: anticoagulation and beyond","volume":"2021","author":"Martin KA","year":"2021","unstructured":"Martin KA, Cuttica MJ. Chronic thromboembolic pulmonary hypertension: anticoagulation and beyond. Hematology Am Soc Hematol Educ Program. 2021, 2021:478-84. 10.1182\/hematology.2021000282","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126985","article-title":"Diagnostic accuracy of computed tomography for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis","volume":"10","author":"Dong C","year":"2015","unstructured":"Dong C, Zhou M, Liu D, Long X, Guo T, Kong X. Diagnostic accuracy of computed tomography for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis. PLoS One. 2015, 10:e0126985. 10.1371\/journal.pone.0126985","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2020.10.026","article-title":"The role of balloon pulmonary angioplasty and pulmonary endarterectomy: is chronic thromboembolic pulmonary hypertension still a life-threatening disease?","volume":"326","author":"Taniguchi Y","year":"2021","unstructured":"Taniguchi Y, Matsuoka Y, Onishi H, et al.. The role of balloon pulmonary angioplasty and pulmonary endarterectomy: is chronic thromboembolic pulmonary hypertension still a life-threatening disease?. Int J Cardiol. 2021, 326:170-7. 10.1016\/j.ijcard.2020.10.026","journal-title":"Int J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14797\/ICHN7633","article-title":"Chronic Thromboembolic Pulmonary Hypertension Medical Management","volume":"17","author":"Logue R","year":"2021","unstructured":"Logue R, Safdar Z. Chronic Thromboembolic Pulmonary Hypertension Medical Management. Methodist Debakey Cardiovasc J. 2021, 17:e29-33. 10.14797\/ICHN7633","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2018.04.110","article-title":"Residual pulmonary hypertension after pulmonary endarterectomy: a meta-analysis","volume":"156","author":"Hsieh WC","year":"2018","unstructured":"Hsieh WC, Jansa P, Huang WC, Ni\u017enansk\u00fd M, Omara M, Lindner J. Residual pulmonary hypertension after pulmonary endarterectomy: a meta-analysis. J Thorac Cardiovasc Surg. 2018, 156:1275-87. 10.1016\/j.jtcvs.2018.04.110","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.12.056","article-title":"Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension","volume":"141","author":"Freed DH","year":"2011","unstructured":"Freed DH, Thomson BM, Berman M, et al.. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg. 2011, 141:383-7. 10.1016\/j.jtcvs.2009.12.056","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-19-0161","article-title":"Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension - a systematic review and meta-analysis","volume":"83","author":"Zoppellaro G","year":"2019","unstructured":"Zoppellaro G, Badawy MR, Squizzato A, Denas G, Tarantini G, Pengo V. Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension - a systematic review and meta-analysis. Circ J. 2019, 83:1660-7. 10.1253\/circj.CJ-19-0161","journal-title":"Circ J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.117.004029","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: results of a multicenter registry","volume":"10","author":"Ogawa A","year":"2017","unstructured":"Ogawa A, Satoh T, Fukuda T, et al.. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: results of a multicenter registry. Circ Cardiovasc Qual Outcomes. 2017, 10:004029. 10.1161\/CIRCOUTCOMES.117.004029","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028831","article-title":"Multicentre randomised controlled trial of balloon pulmonary angioplasty and riociguat in patients with chronic thromboembolic pulmonary hypertension: protocol for the MR BPA study","volume":"10","author":"Kawakami T","year":"2020","unstructured":"Kawakami T, Matsubara H, Abe K, et al.. Multicentre randomised controlled trial of balloon pulmonary angioplasty and riociguat in patients with chronic thromboembolic pulmonary hypertension: protocol for the MR BPA study. BMJ Open. 2020, 10:e028831. 10.1136\/bmjopen-2018-028831","journal-title":"BMJ Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0119-2016","article-title":"Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension","volume":"26","author":"Lang I","year":"2017","unstructured":"Lang I, Meyer BC, Ogo T, et al.. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017, 26:160119. 10.1183\/16000617.0119-2016","journal-title":"Eur Respir Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.112.971077","article-title":"Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension","volume":"5","author":"Mizoguchi H","year":"2012","unstructured":"Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012, 5:748-55. 10.1161\/CIRCINTERVENTIONS.112.971077","journal-title":"Circ Cardiovasc Interv"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2014.12.22933","article-title":"Anticoagulation drug therapy: a review","volume":"16","author":"Harter K","year":"2015","unstructured":"Harter K, Levine M, Henderson SO. Anticoagulation drug therapy: a review. West J Emerg Med. 2015, 16:11-7. 10.5811\/westjem.2014.12.22933","journal-title":"West J Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2019.02.004","article-title":"Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension","volume":"22","author":"van Thor MC","year":"2019","unstructured":"van Thor MC, Ten Klooster L, Snijder RJ, Post MC, Mager JJ. Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension. Int J Cardiol Heart Vasc. 2019, 22:163-8. 10.1016\/j.ijcha.2019.02.004","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2022.02.002","article-title":"Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension","volume":"41","author":"Humbert M","year":"2022","unstructured":"Humbert M, Simonneau G, Pittrow D, et al.. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2022, 41:716-21. 10.1016\/j.healun.2022.02.002","journal-title":"J Heart Lung Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106220","article-title":"Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: final safety data from the EXPERT registry","volume":"178","author":"Ghofrani HA","year":"2021","unstructured":"Ghofrani HA, Gomez Sanchez MA, Humbert M, et al.. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: final safety data from the EXPERT registry. Respir Med. 2021, 178:106220. 10.1016\/j.rmed.2020.106220","journal-title":"Respir Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati A","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009, 339:b2700. 10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0111-2016","article-title":"Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension","volume":"26","author":"Jenkins D","year":"2017","unstructured":"Jenkins D, Madani M, Fadel E, D'Armini AM, Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017, 26:160111. 10.1183\/16000617.0111-2016","journal-title":"Eur Respir Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2005.09.007","article-title":"Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy","volume":"28","author":"Kramm T","year":"2005","unstructured":"Kramm T, Eberle B, Guth S, Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg. 2005, 28:882-8. 10.1016\/j.ejcts.2005.09.007","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2010.11.024","article-title":"Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry","volume":"141","author":"Mayer E","year":"2011","unstructured":"Mayer E, Jenkins D, Lindner J, et al.. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011, 141:702-10. 10.1016\/j.jtcvs.2010.11.024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2021.07.023","article-title":"Experiences with pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension at multiple centers in Taiwan","volume":"121","author":"Liu HY","year":"2022","unstructured":"Liu HY, Wu YJ, Huang SC, Liu CL, Hsu HH, Yu CJ. Experiences with pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension at multiple centers in Taiwan. J Formos Med Assoc. 2022, 121:604-12. 10.1016\/j.jfma.2021.07.023","journal-title":"J Formos Med Assoc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00079704","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"23","author":"Dartevelle P","year":"2004","unstructured":"Dartevelle P, Fadel E, Mussot S, et al.. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004, 23:637-48. 10.1183\/09031936.04.00079704","journal-title":"Eur Respir J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1378\/chest.81.2.151","article-title":"Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data","volume":"81","author":"Riedel M","year":"1982","unstructured":"Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982, 81:151-8. 10.1378\/chest.81.2.151","journal-title":"Chest"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4065\/81.6.777","article-title":"Effects of pulmonary thromboendarterectomy on right-sided echocardiographic parameters in patients with chronic thromboembolic pulmonary hypertension","volume":"81","author":"Casaclang-Verzosa G","year":"2006","unstructured":"Casaclang-Verzosa G, McCully RB, Oh JK, Miller FA Jr, McGregor CG. Effects of pulmonary thromboendarterectomy on right-sided echocardiographic parameters in patients with chronic thromboembolic pulmonary hypertension. Mayo Clin Proc. 2006, 81:777-82. 10.4065\/81.6.777","journal-title":"Mayo Clin Proc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/1476-7120-12-32","article-title":"Assessment of left atrial volume before and after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension","volume":"12","author":"Marston NA","year":"2014","unstructured":"Marston NA, Auger WR, Madani MM, et al.. Assessment of left atrial volume before and after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension. Cardiovasc Ultrasound. 2014, 12:32. 10.1186\/1476-7120-12-32","journal-title":"Cardiovasc Ultrasound"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-15-1208","article-title":"Coagulation-fibrinolysis system and postoperative outcomes of patients with chronic thromboembolic pulmonary hypertension","volume":"80","author":"Kato F","year":"2016","unstructured":"Kato F, Tanabe N, Ishida K, et al.. Coagulation-fibrinolysis system and postoperative outcomes of patients with chronic thromboembolic pulmonary hypertension. Circ J. 2016, 80:970-9. 10.1253\/circj.CJ-15-1208","journal-title":"Circ J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/2045894020918520","article-title":"Life expectancy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Swedish single-center study","volume":"10","author":"Kallonen J","year":"2020","unstructured":"Kallonen J, Glaser N, Bredin F, Corbascio M, Sartipy U. Life expectancy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Swedish single-center study. Pulm Circ. 2020, 10:2045894020918520. 10.1177\/2045894020918520","journal-title":"Pulm Circ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309621","article-title":"Haemodynamic effects of riociguat in inoperable\/recurrent chronic thromboembolic pulmonary hypertension","volume":"103","author":"Kim NH","year":"2017","unstructured":"Kim NH, D'Armini AM, Grimminger F, et al.. Haemodynamic effects of riociguat in inoperable\/recurrent chronic thromboembolic pulmonary hypertension. Heart. 2017, 103:599-606. 10.1136\/heartjnl-2016-309621","journal-title":"Heart"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161827","article-title":"Severe pulmonary arteriopathy is associated with persistent hypoxemia after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension","volume":"11","author":"Jujo T","year":"2016","unstructured":"Jujo T, Tanabe N, Sakao S, et al.. Severe pulmonary arteriopathy is associated with persistent hypoxemia after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. PLoS One. 2016, 11:e0161827. 10.1371\/journal.pone.0161827","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2006.10.020","article-title":"Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension","volume":"133","author":"Reesink HJ","year":"2007","unstructured":"Reesink HJ, van der Plas MN, Verhey NE, van Steenwijk RP, Kloek JJ, Bresser P. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2007, 133:510-6. 10.1016\/j.jtcvs.2006.10.020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/2045894020907883","article-title":"Dynamic vascular changes in chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy","volume":"10","author":"Ruigrok D","year":"2020","unstructured":"Ruigrok D, Braams NJ, Nossent EJ, et al.. Dynamic vascular changes in chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy. Pulm Circ. 2020, 10:2045894020907883. 10.1177\/2045894020907883","journal-title":"Pulm Circ"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2011.09.004","article-title":"Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension","volume":"144","author":"Ishida K","year":"2012","unstructured":"Ishida K, Masuda M, Tanabe N, Matsumiya G, Tatsumi K, Nakajima N. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2012, 144:321-6. 10.1016\/j.jtcvs.2011.09.004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2005.07.033","article-title":"Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension","volume":"131","author":"Thistlethwaite PA","year":"2006","unstructured":"Thistlethwaite PA, Kemp A, Du L, Madani MM, Jamieson SW. Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2006, 131:307-13. 10.1016\/j.jtcvs.2005.07.033","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/1076029614536604","article-title":"Outcome of medically versus surgically treated patients with chronic thromboembolic pulmonary hypertension","volume":"22","author":"Wieteska M","year":"2016","unstructured":"Wieteska M, Biederman A, Kurzyna M, et al.. Outcome of medically versus surgically treated patients with chronic thromboembolic pulmonary hypertension. Clin Appl Thromb Hemost. 2016, 22:92-9. 10.1177\/1076029614536604","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2009.179.1_meetingabstracts.a3325","article-title":"Bosentan as bridge to pulmonary endarterectomy","volume":"54","author":"Reesink HJ","year":"2009","unstructured":"Reesink HJ, Surie S, Kloek JJ, Bresser P. Bosentan as bridge to pulmonary endarterectomy. ATS J. 2009, 54:A3325. 10.1164\/ajrccm-conference.2009.179.1_meetingabstracts.a3325","journal-title":"ATS J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233063","article-title":"Use of medical therapies before pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension patients with severe hemodynamic impairment","volume":"15","author":"Castro MA","year":"2020","unstructured":"Castro MA, Piloto B, Dos Santos Fernandes CJ, et al.. Use of medical therapies before pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension patients with severe hemodynamic impairment. PLoS One. 2020, 15:e0233063. 10.1371\/journal.pone.0233063","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02095-2018","article-title":"French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension","volume":"53","author":"Brenot P","year":"2019","unstructured":"Brenot P, Ja\u00efs X, Taniguchi Y, et al.. French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019, 53:1802095. 10.1183\/13993003.02095-2018","journal-title":"Eur Respir J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-15-1212","article-title":"Multiple beneficial effects of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension","volume":"80","author":"Tatebe S","year":"2016","unstructured":"Tatebe S, Sugimura K, Aoki T, et al.. Multiple beneficial effects of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2016, 80:980-8. 10.1253\/circj.CJ-15-1212","journal-title":"Circ J"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-303549","article-title":"Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension","volume":"99","author":"Andreassen AK","year":"2013","unstructured":"Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013, 99:1415-20. 10.1136\/heartjnl-2012-303549","journal-title":"Heart"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2021.03.002","article-title":"Assessment of oxygenation after balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension","volume":"333","author":"Matsuoka Y","year":"2021","unstructured":"Matsuoka Y, Taniguchi Y, Miwa K, et al.. Assessment of oxygenation after balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2021, 333:188-94. 10.1016\/j.ijcard.2021.03.002","journal-title":"Int J Cardiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2020.09.016","article-title":"Efficacy and safety of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension","volume":"120","author":"Chen ZW","year":"2021","unstructured":"Chen ZW, Wu CK, Kuo PH, et al.. Efficacy and safety of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. J Formos Med Assoc. 2021, 120:947-55. 10.1016\/j.jfma.2020.09.016","journal-title":"J Formos Med Assoc"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2021-001721","article-title":"Characteristics and in-hospital outcomes of patients undergoing balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a time-trend analysis from the Japanese nationwide registry","volume":"8","author":"Minatsuki S","year":"2021","unstructured":"Minatsuki S, Takahara M, Kiyosue A, et al.. Characteristics and in-hospital outcomes of patients undergoing balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a time-trend analysis from the Japanese nationwide registry. Open Heart. 2021, 8:e001721. 10.1136\/openhrt-2021-001721","journal-title":"Open Heart"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2019.07.006","article-title":"Effectiveness of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension despite having lesion types suitable for surgical treatment","volume":"75","author":"Minatsuki S","year":"2020","unstructured":"Minatsuki S, Kiyosue A, Kodera S, et al.. Effectiveness of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension despite having lesion types suitable for surgical treatment. J Cardiol. 2020, 75:182-8. 10.1016\/j.jjcc.2019.07.006","journal-title":"J Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2020.02.015","article-title":"Balloon pulmonary angioplasty improves quality of life in Japanese patients with chronic thromboembolic pulmonary hypertension","volume":"76","author":"Minatsuki S","year":"2020","unstructured":"Minatsuki S, Kodera S, Kiyosue A, et al.. Balloon pulmonary angioplasty improves quality of life in Japanese patients with chronic thromboembolic pulmonary hypertension. J Cardiol. 2020, 76:205-10. 10.1016\/j.jjcc.2020.02.015","journal-title":"J Cardiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263244","article-title":"The effectiveness of scoring balloon angioplasty in the treatment of chronic thromboembolic pulmonary hypertension","volume":"17","author":"Takigami M","year":"2022","unstructured":"Takigami M, Tsubata H, Nakanishi N, et al.. The effectiveness of scoring balloon angioplasty in the treatment of chronic thromboembolic pulmonary hypertension. PLoS One. 2022, 17:e0263244. 10.1371\/journal.pone.0263244","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-309230","article-title":"Efficacy of cardiac rehabilitation after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension","volume":"102","author":"Fukui S","year":"2016","unstructured":"Fukui S, Ogo T, Takaki H, et al.. Efficacy of cardiac rehabilitation after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Heart. 2016, 102:1403-9. 10.1136\/heartjnl-2015-309230","journal-title":"Heart"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255180","article-title":"Exercise tolerance and quality of life in hemodynamically partially improved patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty","volume":"16","author":"Miura K","year":"2021","unstructured":"Miura K, Katsumata Y, Kawakami T, et al.. Exercise tolerance and quality of life in hemodynamically partially improved patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty. PLoS One. 2021, 16:e0255180. 10.1371\/journal.pone.0255180","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254770","article-title":"A pilot cohort study assessing the feasibility of complete revascularization with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension","volume":"16","author":"Fujii S","year":"2021","unstructured":"Fujii S, Nagayoshi S, Ogawa K, et al.. A pilot cohort study assessing the feasibility of complete revascularization with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. PLoS One. 2021, 16:e0254770. 10.1371\/journal.pone.0254770","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0094-2018","article-title":"Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review","volume":"27","author":"van der Wall SJ","year":"2018","unstructured":"van der Wall SJ, van der Pol LM, Ende-Verhaar YM, et al.. Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review. Eur Respir Rev. 2018, 27:180094. 10.1183\/16000617.0094-2018","journal-title":"Eur Respir Rev"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.628284","article-title":"Association between anticoagulation outcomes and venous thromboembolism history in chronic thromboembolic pulmonary hypertension","volume":"8","author":"Zhu YJ","year":"2021","unstructured":"Zhu YJ, Zhou YP, Wei YP, et al.. Association between anticoagulation outcomes and venous thromboembolism history in chronic thromboembolic pulmonary hypertension. Front Cardiovasc Med. 2021, 8:628284. 10.3389\/fcvm.2021.628284","journal-title":"Front Cardiovasc Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14649","article-title":"A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension","volume":"18","author":"Bunclark K","year":"2020","unstructured":"Bunclark K, Newnham M, Chiu YD, et al.. A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2020, 18:114-22. 10.1111\/jth.14649","journal-title":"J Thromb Haemost"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08206.x","article-title":"Risk factors for venous thrombosis - current understanding from an epidemiological point of view","volume":"149","author":"Lijfering WM","year":"2010","unstructured":"Lijfering WM, Rosendaal FR, Cannegieter SC. Risk factors for venous thrombosis - current understanding from an epidemiological point of view. Br J Haematol. 2010, 149:824-33. 10.1111\/j.1365-2141.2010.08206.x","journal-title":"Br J Haematol"},{"key":"ref52","article-title":"Warfarin","author":"Patel S","year":"2022","unstructured":"Patel S, Singh R, Preuss CV, Patel N. Warfarin. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/dj4010005","article-title":"New direct oral anticoagulants (DOAC) and their use today","volume":"4","author":"Schwarb H","year":"2016","unstructured":"Schwarb H, Tsakiris DA. New direct oral anticoagulants (DOAC) and their use today. Dent J (Basel). 2016, 4:5. 10.3390\/dj4010005","journal-title":"Dent J (Basel)"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.117232","article-title":"Comprehensive landscape of heparin therapy for COVID-19","volume":"254","author":"Shi C","year":"2021","unstructured":"Shi C, Tingting W, Li JP, et al.. Comprehensive landscape of heparin therapy for COVID-19. Carbohydr Polym. 2021, 254:117232. 10.1016\/j.carbpol.2020.117232","journal-title":"Carbohydr Polym"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.24.2994","article-title":"Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association","volume":"103","author":"Hirsh J","year":"2001","unstructured":"Hirsh J, Anand SS, Halperin JL, Fuster V. Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. Circulation. 2001, 103:2994-3018. 10.1161\/01.cir.103.24.2994","journal-title":"Circulation"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202005-521OC","article-title":"A survey-based estimate of COVID-19 incidence and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension and impact on the process of care","volume":"17","author":"Lee JD","year":"2020","unstructured":"Lee JD, Burger CD, Delossantos GB, et al.. A survey-based estimate of COVID-19 incidence and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension and impact on the process of care. Ann Am Thorac Soc. 2020, 17:1576-82. 10.1513\/AnnalsATS.202005-521OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.9739\/tjvs.2021.748","article-title":"How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: too many gray zones to be considered","volume":"30","author":"Akay T","year":"2021","unstructured":"Akay T, Sade LE, Bozba\u015f S, et al.. How to deal with chronic thromboembolic pulmonary arterial hypertension (CTEPH) during the COVID-19 pandemic: too many gray zones to be considered. Turkish J Vascular Surg. 2021, 30:70-6. 10.9739\/tjvs.2021.748","journal-title":"Turkish J Vascular Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/224126-role-of-surgical-and-medical-management-of-chronic-thromboembolic-pulmonary-hypertension-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:31Z","timestamp":1707509611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/224126-role-of-surgical-and-medical-management-of-chronic-thromboembolic-pulmonary-hypertension-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":57,"URL":"https:\/\/doi.org\/10.7759\/cureus.53336","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,31]]}}}